Used as an intermediate in the synthesis of sulfonamide-based pharmaceuticals, particularly in the development of carbonic anhydrase inhibitors. These inhibitors are applied in the treatment of glaucoma, epilepsy, and certain types of edema. Its structure supports the design of compounds with high affinity for enzyme active sites, enhancing therapeutic efficacy. Also explored in the preparation of novel antimicrobial agents due to the inherent biological activity of sulfonamide derivatives.